Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- CNTX
- Price
- 0.57
- Stock movement down
- -0.02 (-2.74%)
- Company name
- Context Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 78.94M
- Ent value
- -3.39M
- Price/Sales
- 4165.24
- Price/Book
- 0.94
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -65.22%
- 3 year return
- -22.90%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CNTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4165.24 |
| Price to Book | 0.94 |
| EV to Sales | -178.85 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 89.70M |
| EPS (TTM) | -0.37 |
| FCF per share (TTM) | -0.21 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 18.95K |
| Gross profit (TTM) | 11.25K |
| Operating income (TTM) | -32.55M |
| Net income (TTM) | -30.15M |
| EPS (TTM) | -0.37 |
| EPS (1y forward) | -0.39 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 59.35% |
| Operating margin (TTM) | -171732.15% |
| Profit margin (TTM) | -159097.10% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 84.80M |
| Net receivables | 0.00 |
| Total current assets | 86.07M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 259.03K |
| Total assets | 86.33M |
| Accounts payable | 1.03M |
| Short/Current long term debt | 244.36K |
| Total current liabilities | 2.33M |
| Total liabilities | 2.47M |
| Shareholder's equity | 83.86M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -16.88M |
| Capital expenditures (TTM) | 7.32K |
| Free cash flow (TTM) | -16.88M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -35.96% |
| Return on Assets | -34.93% |
| Return on Invested Capital | -35.91% |
| Cash Return on Invested Capital | -20.11% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.89 |
| Daily high | 0.90 |
| Daily low | 0.85 |
| Daily Volume | 71K |
| All-time high | 7.45 |
| 1y analyst estimate | 5.20 |
| Beta | 1.89 |
| EPS (TTM) | -0.37 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 5 Nov 2025 |
Downside potential
Loading...
Downside potential data
| CNTX | S&P500 | |
| Current price drop from All-time high | -88.19% | -1.46% |
| Highest price drop | -93.53% | -56.47% |
| Date of highest drop | 4 May 2023 | 9 Mar 2009 |
| Avg drop from high | -79.37% | -10.99% |
| Avg time to new high | 240 days | 12 days |
| Max time to new high | 959 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
78.94M
Marketcap category
Small-cap
Description
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Employees
12
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page